Hepatitis Weekly

Hepatitis C Virus - New hepatitis C virus study findings have been reported by researchers at University of Padova, Venetian Institute of Molecular Medicine

Hepatitis C Virus - New hepatitis C virus study findings have been reported from Ben-Gurion University

Hepatitis C Virus - Research by C. Romero-López and colleagues in hepatitis C virus provides new insights

Hepatitis C Virus - Researchers at Stanford University have published new data on hepatitis C virus

Hepatitis C Virus - Studies conducted at University of Bologna on hepatitis C virus recently published

Hepatitis C Virus Epidemiology - Data from E. Spada et al provide new insights into hepatitis C virus epidemiology

Hepatitis C Virus Gene Therapy - New findings from University of Texas, Department of Molecular Genetics describe advances in hepatitis C virus gene therapy

Hepatitis C Virus Gene Therapy - Study results from Scripps Research Institute, Department of Chemistry provide new insights into hepatitis C virus gene therapy

Hepatitis C Virus Genetics - Studies from Hospital Vall D'Hebron, Department of Medicine yield new information about hepatitis C virus genetics

Hepatitis C Virus Risk Factors - Data on hepatitis C virus risk factors discussed by B. Fischer and colleagues

Hepatitis C Virus Risk Factors - Studies from National Institutes of Health yield new data on hepatitis C virus risk factors

Hepatitis C Virus Therapy - New hepatitis C virus therapy study findings have been reported by scientists at Tokyo Metropolitan Institute of Medical Science

Hepatitis C Virus Therapy - New hepatitis C virus therapy study findings recently were published by researchers at Medical University of Vienna, Institute of Neurology

Hepatitis C Virus Therapy - Research from University of Valencia in the area of hepatitis C virus therapy published

Hepatitis C Virus Therapy - Studies in the area of hepatitis C virus therapy reported from University of Turin

Hepatitis D Virus - New findings from University Nova of Lisboa in the area of hepatitis D virus described

Hepatitis D Virus Gene Therapy - Researchers from Baylor College of Medicine discuss findings in hepatitis D virus gene therapy

Hepatitis E Virus - Researchers from All India Institute of Medical Sciences, Department of Pathology publish new studies and findings in the area of hepatitis E virus

Hepatitis E Virus - Study results from Purpan University update understanding of hepatitis E virus

Hepatocellular Cancer - Research conducted at Rikshospitalet-Radiumhospitalet Medical Center, Department of Medicine has updated our knowledge about hepatocellular cancer

HIV/AIDS Therapy - Research from Royal Melbourne Hospital provides new data about HIV/AIDS therapy

HIV/AIDS Therapy - Study findings on HIV/AIDS therapy are outlined in reports from University of Barcelona, Department of Infectious Diseases

Life Sciences - Research findings from INSERM update understanding of life sciences

Thalassemia - Research from Canadian Blood Services in the area of thalassemia described

Transfusion Medicine - Study results from Canadian Blood Services in the area of transfusion medicine published

Aplastic Anemia - Research from Nagoya University, Medical Department has provided new information about aplastic anemia

Cirrhosis - Research from Yamaguchi University, Medical Department has provided new information about cirrhosis

Alcoholism Therapy - Data on alcoholism therapy reported by L.C. Faria and co-researchers

Diabetes - Research from Children's Hospital, Division of Developmental Biology yields new findings on diabetes

Fujimoto Disease Immunology - Research from Royal Free Hospital has provided new information about fujimoto disease immunology

Necrosis - Scientists at National Institute of Biomedical Innovation describe research in necrosis

Breast Cancer - Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer

Hepatitis C Virus - Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R)

Hepatitis C Virus - Vertex Pharmaceuticals to Begin Phase 3 Development of Telaprevir, Investigational Hepatitis C Protease Inhibitor

HIV/AIDS - Fair Pricing Coalition Lauds Pricing of New Tibotec Drug

Non-Small Cell Lung Cancer - Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer

Peregrine Pharmaceuticals, Inc. - Peregrine Pharmaceuticals Receives 180-DAY Extension From Nasdaq to Regain Compliance With $1.00 Minimum Bid Price Rule